{
    "clinical_study": {
        "@rank": "68701", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Active", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Prednisolone"
            }
        ], 
        "brief_summary": {
            "textblock": "The main purpose of the trial is to advance our knowledge on the possible mechanism\n      underlying the catabolic effects of long-term treatment with glucocorticoid. More\n      specifically the investigators are interested in the molecular mechanisms by which\n      glucocorticoid inhibits growth."
        }, 
        "brief_title": "Glucocorticoid Induced Inhibition of IGF-I Activity: Exploring Underlying Mechanisms.", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Focus of Study: Prednisolone Induced Catabolic Effects", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  signed and dated informed consent\n\n          -  healthy subjects\n\n          -  sex: male\n\n          -  age 20-30 years\n\n          -  BMI 19-26 kg/m2\n\n          -  normal HbA1c\n\n        Exclusion Criteria:\n\n          -  suspected og known allergy to the trial drug or similar medications.\n\n          -  known current illness including diabetes mellitus, ischemic heart disease or cardiac\n             arrhythmia.\n\n          -  Daily drug intake (excluding Over-the-Counter medicines).\n\n          -  Known or previous mental illness\n\n          -  Current participation or previous participation in experiments using ionizing\n             radiation for a year prior to inclusion in this study.\n\n          -  Participation in a larger X-ray examinations in trial period."
            }, 
            "gender": "Male", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "30 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01762540", 
            "org_study_id": "GK_nilani_2012"
        }, 
        "intervention": {
            "arm_group_label": "Active", 
            "intervention_name": "Prednisolone", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Glucocorticoids", 
                "Prednisolone", 
                "Methylprednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate", 
                "Methylprednisolone acetate", 
                "Prednisolone acetate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Protein breakdown", 
            "Insulin resistance", 
            "Glucose intolerance", 
            "Lipolysis"
        ], 
        "lastchanged_date": "January 4, 2013", 
        "location": {
            "contact": {
                "email": "nilani.ramshanker@ki.au.dk", 
                "last_name": "Nilani Ramshanker, Doctor", 
                "phone": "+45 78462154"
            }, 
            "contact_backup": {
                "last_name": "Jan Frystyk, Doctor", 
                "phone": "+45 89492166"
            }, 
            "facility": {
                "address": {
                    "city": "Aarhus", 
                    "country": "Denmark", 
                    "zip": "8000"
                }, 
                "name": "Medical Research Laboratory, Clinical Institute of Medicine, Aarhus University Hospital"
            }, 
            "investigator": {
                "last_name": "Nilani Ramshanker, Doctor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Glucocorticoid Induced Inhibition of IGF-I Activity: Exploring Underlying Mechanisms.", 
        "overall_contact": {
            "email": "nilani.ramshanker@ki.au.dk", 
            "last_name": "Nilani Ramshanker, Doctor", 
            "phone": "+45 78462154"
        }, 
        "overall_contact_backup": {
            "email": "jan.frystyk@ki.au.dk", 
            "last_name": "Jan Frystyk, Doctor", 
            "phone": "+45 89492166"
        }, 
        "overall_official": {
            "affiliation": "Medical Research Laboratory, Clinical institute of Medicine, Aarhus University Hospital", 
            "last_name": "Jan Frystyk, Doctor, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Blood-test before (day 1) during (day 3) and at the end (day 5) of placebo/prednisolone treatment.", 
            "measure": "Insulin-like Growth Factor (IGF)-I profiles of subjects before and after prednisolone-treatment.", 
            "safety_issue": "No", 
            "time_frame": "day 1, 3 and 5"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01762540"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Tissue biopsy on day 5.", 
                "measure": "Intracellular signaling of IGF-I under the influence/abscence of prednisolone.", 
                "safety_issue": "No", 
                "time_frame": "day 5"
            }, 
            {
                "description": "Hyperinsulinemic euglycemic clamp on day 5.", 
                "measure": "Insulin sensitivity under the influence/abscence of prednisolone.", 
                "safety_issue": "No", 
                "time_frame": "Day 5"
            }
        ], 
        "source": "University of Aarhus", 
        "sponsors": {
            "collaborator": {
                "agency": "The Ministry of Science, Technology and Innovation, Denmark", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Aarhus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}